Clinical Trials Logo

Recovery clinical trials

View clinical trials related to Recovery.

Filter by:

NCT ID: NCT05607875 Completed - Mental Disorders Clinical Trials

The Grow to Recovery Train-the-Trainer Program

Start date: November 2, 2022
Phase: N/A
Study type: Interventional

Recovery-oriented services are becoming popular in the mental health field. However, recovery-oriented services are still in the beginning stages in Taiwan. Many professionals do not know how to implement recovery-oriented services. More effort should be made to improve mental health services in Taiwan. Hence, the aim of this study is to examine the effectiveness of the Grow to Recovery Train-the-Trainer program.

NCT ID: NCT05589129 Active, not recruiting - Sleep Clinical Trials

Whey Protein Supplementation in High School Athletes

Start date: July 14, 2022
Phase: N/A
Study type: Interventional

The overall aim of this project is to compare protein supplementation on performance, recovery, and body composition changes in adolescent soccer players between the whey protein and the control group in response to the 10-12-week intervention.

NCT ID: NCT05453812 Recruiting - Lung Cancer Clinical Trials

Meaning of Recovery After Lung Cancer Surgery

Start date: July 18, 2022
Phase:
Study type: Observational

The purpose of this study is to find out the meaning of recovery after lung cancer surgery from a patient's point of view. The results of this study would help improve postoperative recovery in lung cancer patients.

NCT ID: NCT05435911 Completed - Recovery Clinical Trials

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

Start date: August 2, 2022
Phase: N/A
Study type: Interventional

This prospective randomized trial aims to compare recovery time from discontinuation of remimazolam followed by flumazenil administration vs. propofol-based total intravenous anesthesia in patients undergoing breast cancer surgery.

NCT ID: NCT05406102 Not yet recruiting - Safety Clinical Trials

Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy

Start date: July 10, 2022
Phase: Phase 4
Study type: Interventional

Gastroenteroscopy diagnosis and treatment drugs need to meet the needs of quick onset, quick recovery and less anesthesia complications. Remimazolam is an anesthetic sedative independently developed by China. It is a new short-acting GABA(A) receptor agonist. Remimazolam has the advantages of rapid onset, rapid recovery, antagonist, controllable degree of cardiovascular and respiratory depression, low incidence of hypotension and respiratory depression. However, elderly patients as important and special patients, there are still a lack of relevant studies and reports. In order to verify the safety and effectiveness of remimazolam in the gastroenteroscopy treatment of elderly patients, it can reduce the incidence of intraoperative hypotension or respiratory depression rate, improve the quality of recovery of elderly patients.

NCT ID: NCT05397886 Completed - Recovery Clinical Trials

Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation

Start date: August 2, 2022
Phase: N/A
Study type: Interventional

This prospective randomized trial aims to compare recovery time from discontinuation of remimazolam followed by flumazenil administration vs. propofol total intravenous anesthesia as the main general anesthetics during radiofrequency catheter ablation treatment of atrial fibrillation.

NCT ID: NCT05307107 Completed - Physical Activity Clinical Trials

Educators' Digital Occupational Well-being Intervention During Working Hours

SHINE
Start date: February 7, 2022
Phase: N/A
Study type: Interventional

This controlled quasi experimental intervention study follows the MRC framework for complex interventions (Bleijenberg et al. 2018) aiming to promote educators' individual aspect of occupational well-being. The purpose of this study is: 1) to evaluate the effectiveness of 8-workweek SHINE (= Self-Help INtervention for Educators) on educator's individual aspect of occupational well-being comparing intervention and control groups and 2) to describe the possible associating factors for the effectiveness of the intervention (if any) and 3) to evaluate SHINE's acceptability (utility and usability) within intervention group.

NCT ID: NCT05304780 Completed - Schizophrenia Clinical Trials

Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia

Start date: July 15, 2020
Phase: N/A
Study type: Interventional

Meeting people's needs is positively correlated with their recovery. However, recovery services rarely include nurse-led programs tailored to the needs of these people. This study aimed to evaluate the effectiveness of a new needs-tailored recovery program by using a cluster-randomized controlled trial design.

NCT ID: NCT05220371 Completed - Recovery Clinical Trials

Influence of Specific Collagen Peptides on Recovery After Exercise Induced Muscle Damage

Start date: January 28, 2022
Phase: N/A
Study type: Interventional

The present study aims at investigating the potential influence of specific collagen peptides on recovery after exercise induced muscle damage with focus on long-term effects.

NCT ID: NCT05097027 Completed - Resistance Training Clinical Trials

Blood Flow Restriction and Recovery in Soccer Players

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The objective is to evaluate the effects of blood flow restriction training on the post-competition recovery of professional and semi-professional soccer players. Randomized crossover clinical trial, with two intervention groups: Experimental group I will carry out a recovery training based on the use of the blood flow restriction (BFR) on day 1 post-competition. On the other hand, the Experimental II group will perform the same recovery training without the use of BFR. After 1 month the groups will cross their intervention and make the recovery with the opposite method to the initial one. The study will be carried out during the 2021-2022 season, from first regional to third division of Spanish soccer, with soccer teams from the Mallorca Island. Before the competition, the countermovement jump (CMJ) will be evaluated and repeated at 0, 24, and 72 h after the competition. The levels of muscle soreness (DOMS) will be evaluated pre-post-competition 0, 24, 48 and 72h later. The same procedure will be carried out to evaluate muscle fatigue, sleep quality, and stress through a questionnaire that athletes will fill out pre, 0, 24, 48 and 72h after the game. Sociodemographic and anthropometric data will be collected before starting the study.